1.54 USD
↘ 0.02 (1.28%)AT CLOSE (11:59 AM EDT)
ALX Oncology Holdings Inc. Common Stock
ALXONASDAQ • USD
1.55
↗ 0.01 (0.33%)
POST MARKET (AS OF 07:33 PM EDT)
Post Market
AS OF 07:33 PM EDT
1.55
↗ 0.01 (0.33%)
Market: CLOSED
Open?$1.58
High?$1.64
Low?$1.52
Prev. Close?$1.56
Volume?858.5K
Avg. Volume?992.2K
VWAP?$1.58
Rel. Volume?0.87x
Bid / Ask
Bid?$1.30 × 100
Ask?$1.76 × 100
Spread?$0.46
Midpoint?$1.53
Valuation & Ratios
Market Cap?207.2M
Shares Out?134.6M
Float?92.5M
Float %?68.8%
P/E Ratio?N/A
P/B Ratio?1.37
EPS?-$0.66
Dividend?0.00%
Ex-Dividend?N/A
ALX Oncology Holdings Inc. Common Stock (ALXO) trades at $1.54 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics suggest ALXO is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. It is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
Employees
43
Market Cap
207.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-07-17
Address
323 ALLERTON AVENUE
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-466-7125
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-466-7125
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?65
Short Sent.?74
Piotroski F-Score?0/9Weak
Altman Z-Score?-2.05Distress
Confidence?42%Low
Short InterestLow
Short % of Float?1.49%Low
Short Interest?1.4M
Days to Cover?1.9
Free Float92.5M
Avg Daily Volume713.8K
Settlement Date2026-05-15
Financial Health
Current Ratio?7.21Strong
Quick Ratio?7.21Strong
Cash Ratio?1.60Strong
Debt/Equity?0.06Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.37CHEAP▾
Peers100
S&P90
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-2.1CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-58.7%WEAK▾
S&P3
ROA?-49.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-78329000
Enterprise Value?$183.5M
Fundamentals ratios updated end of day